Division of Population Health
REGzG
REGzG
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Call to Action<br />
Monitoring Vaccination Rates for Shingles<br />
Shingles, also known as herpes zoster, is a disease that causes a painful skin rash. It<br />
can also lead to severe pain that can last for months or even years after the rash goes<br />
away, a condition known as post-herpetic neuralgia. Pain from shingles has been<br />
described as excruciating, aching, burning, stabbing, and shock-like. It can cause<br />
depression, anxiety, difficulty concentrating, loss <strong>of</strong> appetite, and weight loss. Shingles<br />
may interfere with activities <strong>of</strong> daily living, such as dressing, bathing, eating, cooking,<br />
shopping, and travel. To prevent shingles, CDC recommends that people aged 60<br />
years or older receive a onetime vaccination. 27<br />
To date, only national data have been available to monitor the use <strong>of</strong> the shingles<br />
vaccine. In 2010, 14.4% <strong>of</strong> adults aged 60 or older reported receiving the vaccine, an<br />
increase from the 10% reported in 2009. 28 Recognizing the need for state and selected<br />
MMSA (metropolitan and micropolitan statistical area) data, CDC created a question<br />
about shingles vaccination for the BRFSS survey. Since 2009, this question has been<br />
available as an optional module that states can use to ask about the receipt <strong>of</strong> shingles<br />
vaccination among adults aged 50 years or older. Five states used the question in 2009<br />
and six states used it in 2010. 29<br />
Starting in 2014, the shingles vaccination question will be part <strong>of</strong> the BRFSS “core”<br />
questionnaire that all states use every 3 years. These data will allow states and MMSAs<br />
to monitor trends in vaccination rates and identify disparities. Program planners can<br />
use this information to identify problems so they can adopt corrective strategies.<br />
Indicator 13. Colorectal cancer screening<br />
• This report identifies the percentage <strong>of</strong> older adults who have been screened for<br />
colorectal cancer by having a fecal occult blood test (FOBT) during the past year, a<br />
flexible sigmoidoscopy within 5 years and FOBT within 3 years, or a colonoscopy<br />
within 10 years.<br />
• Colorectal cancer almost always develops from precancerous polyps (abnormal<br />
growths) in the colon or rectum. Screening tests can find precancerous polyps so that<br />
they can be removed before they turn into cancer. They can also detect colorectal<br />
cancer early, when treatment works best. 33<br />
• Two-thirds <strong>of</strong> all new cases <strong>of</strong> colorectal cancer are in people aged 65 or older. 34<br />
The State <strong>of</strong> Aging and <strong>Health</strong> in America 2013 PAGE 23